KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Sales (2017 - 2025)

Sarepta Therapeutics has reported Return on Sales over the past 12 years, most recently at 0.01% for Q4 2025.

  • For Q4 2025, Return on Sales rose 1.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Sales for Q4 2025 was 0.01% at Sarepta Therapeutics, up from 0.0% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.01% in Q4 2021 and troughed at 0.23% in Q1 2023.
  • A 5-year average of 0.02% and a median of 0.0% in 2021 define the central range for Return on Sales.
  • Biggest five-year swings in Return on Sales: dropped -23bps in 2023 and later grew 24bps in 2024.
  • Year by year, Return on Sales stood at 0.01% in 2021, then crashed by -85bps to 0.0% in 2022, then surged by 66bps to 0.0% in 2023, then dropped by -20bps to 0.0% in 2024, then soared by 230bps to 0.01% in 2025.
  • Business Quant data shows Return on Sales for SRPT at 0.01% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.